J Neuropsychiatry Clin Neurosci 1997; 9:273-276
Copyright © 1997 by American Neuropsychiatric Association
Manic episodes in two patients treated with interferon alpha
D Strite, AD Valentine and CA Meyers
Department of Neuro-Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
The authors report the assessment of 2 patients on interferon alpha
(IFN-alpha) therapy for chronic myelogenous leukemia who developed manic
symptoms long after IFN-alpha therapy had been initiated. These cases
suggest that chronic IFN-alpha therapy may be associated with vulnerability
for developing overt psychiatric symptoms, particularly in cases where the
patient is experiencing psychosocial stress, and that the current
definition of persistent adverse effects of IFN-alpha should be broadened
to include the occurrence of manic episodes.
This article has been cited by other articles:
|
|
|
|
 
C. C. Crone, G. M. Gabriel, and A. DiMartini
An Overview of Psychiatric Issues in Liver Disease for the Consultation-Liaison Psychiatrist
Psychosomatics,
June 1, 2006;
47(3):
188 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. Mistler, M. F. Brunette, B. J. Marsh, R. M. Vidaver, R. Luckoor, and S. D. Rosenberg
Hepatitis C treatment for people with severe mental illness.
Psychosomatics,
March 1, 2006;
47(2):
93 - 107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. U. Onyike, J. O. Bonner, C. G. Lyketsos, and G. J. Treisman
Mania During Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin
Am J Psychiatry,
March 1, 2004;
161(3):
429 - 435.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Russo, I. P. Kema, M. R. Fokkema, J. C. Boon, P. H. B. Willemse, E. G. E. de Vries, J. A. den Boer, and J. Korf
Tryptophan as a Link between Psychopathology and Somatic States
Psychosom Med,
July 1, 2003;
65(4):
665 - 671.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Garcia-Pares, C. Domenech, and M. Gil
Psychosis Induced by Interferon-{alpha}
Psychosomatics,
October 1, 2002;
43(5):
428 - 429.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Kirkwood, C. Bender, S. Agarwala, A. Tarhini, J. Shipe-Spotloe, B. Smelko, S. Donnelly, and L. Stover
Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy
J. Clin. Oncol.,
September 1, 2002;
20(17):
3703 - 3718.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Jonasch and F. G. Haluska
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities
Oncologist,
February 1, 2001;
6(1):
34 - 55.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. C. Trask, P. Esper, M. Riba, and B. Redman
Psychiatric Side Effects of Interferon Therapy: Prevalence, Proposed Mechanisms, and Future Directions
J. Clin. Oncol.,
June 11, 2000;
18(11):
2316 - 2326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Dieperink, M. Willenbring, and S. B. Ho
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Am J Psychiatry,
June 1, 2000;
157(6):
867 - 876.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Z. Kronfol and D. G. Remick
Cytokines and the Brain: Implications for Clinical Psychiatry
Am J Psychiatry,
May 1, 2000;
157(5):
683 - 694.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. M. Lerner, A. Stoudemire, and D. L. Rosenstein
Neuropsychiatric Toxicity Associated With Cytokine Therapies
Psychosomatics,
October 1, 1999;
40(5):
428 - 435.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Monji, I. Yoshida, K.-i. Tashiro, Y. Hayashi, and N. Tashiro
A Case of Persistent Manic Depressive Illness Induced by Interferon-Alfa in the Treatment of Chronic Hepatitis C
Psychosomatics,
December 1, 1998;
39(6):
562 - 564.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1997
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
